NOTCH1 and acute lymphoblastic leukemia: Despite the fact that Notch mutations are driving its overexpression in T-ALL, NOTCH1 mutations are not predictive of prognosis and do not appear to be a useful biomarker aside from an observed association with improved early therapeutic response in T-ALL patients [54].